BP Control Down in the United States From 2013-2014 to 2017-2018
BP control, awareness, treatment down in adults aged 40 to 59 years from 2009-2012 to 2015-2018
NIH Launches Clinical Trials of Antithrombotics for COVID-19
Adaptive design allows evaluation of various doses, types of blood thinners in outpatients, inpatients
Some Doctors Not Following Guidelines for Diagnosing HTN
Most providers rely on clinic BP measurements; almost all use clinic BP threshold of 140/90 mm Hg
Rates of Ambulatory Heart Failure Steady From 2001 to 2016
Greatest disparities seen between Black and White adults aged 35 to 64 years
Future Cardiovascular Event Risk Up With High BP in Young Adults
Graded progressive link seen between categories of blood pressure and increased risk for CV events
Smokeless Tobacco Poses Global Health Burden
Greatest burden of smokeless tobacco-related disease found in South and Southeast Asia
Moderate, Heavy Drinking Linked to Increased BP, HTN in T2DM
Odds of elevated blood pressure and stage 1, 2 hypertension increased with moderate drinking
CDC: Nearly 800 U.S. Children Have Developed COVID-19-Related Condition
Multisystem inflammatory syndrome in children also associated with 16 deaths reported in 42 states
Controlled BP Down Among U.S. Adults With HTN After 2013–2014
Controlled BP more likely among those aged 45 to 64 years, less likely for those aged 75 years or older
Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns
Prevalence of care avoidance higher for caregivers, those with underlying conditions, disabilities
